Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03092934
Title A Study of AK-01 (LY3295668) in Solid Tumors
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

lung small cell carcinoma

Her2-receptor negative breast cancer

Advanced Solid Tumor

Therapies

LY3295668

Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
McGill University Montreal Quebec H4A 3J1 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field